Bio Essence Corp (BIOE): Depreciation & Amortization
$235
Year ended 2025-12-31
$103.8K
Trailing 12 months to 2026-06-30
-74.7%
3-year compound annual growth
-62.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $235 | -74.2% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $911 | -81.0% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $4.8K | -67.0% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $14.5K | -59.5% | 2024-04-15, From 2022-01-01 |
| 2021-12-31 | $35.8K | +7.6% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $33.3K | n/a | 2022-03-31, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Bio Essence Corp (BIOE) | 2025-12-31 | $235 | -74.2% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $60.8K | +47.9% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $900.0K | -12.5% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $68.8K | -27.9% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $70.0K | n/m |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $2.06M | +18.3% |
| Cannapharmarx, Inc. (CPMD) | 2024-12-31 | $0 | -100.0% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $618.0K | -3.0% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $199.0K | +32.7% |
Compare BIOE, LPCN, RANI, GOVX side by side · Screen every company in Pharmaceutical Preparations ↗